The Interleukin-8 Pathway in Cancer
Top Cited Papers
- 1 November 2008
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (21), 6735-6741
- https://doi.org/10.1158/1078-0432.ccr-07-4843
Abstract
Interleukin-8 (IL-8) is a proinflammatory CXC chemokine associated with the promotion of neutrophil chemotaxis and degranulation. This chemokine activates multiple intracellular signaling pathways downstream of two cell-surface, G protein–coupled receptors (CXCR1 and CXCR2). Increased expression of IL-8 and/or its receptors has been characterized in cancer cells, endothelial cells, infiltrating neutrophils, and tumor-associated macrophages, suggesting that IL-8 may function as a significant regulatory factor within the tumor microenvironment. The induction of IL-8 signaling activates multiple upstream signaling pathways that (a) impinge on gene expression via regulation of numerous transcription factor activities, (b) modulate the cellular proteome at the level of translation, and/or (c) effect the organization of the cell cytoskeleton through posttranslational regulation of regulatory proteins. As a consequence of the diversity of effectors and downstream targets, IL-8 signaling promotes angiogenic responses in endothelial cells, increases proliferation and survival of endothelial and cancer cells, and potentiates the migration of cancer cells, endothelial cells, and infiltrating neutrophils at the tumor site. Accordingly, IL-8 expression correlates with the angiogenesis, tumorigenicity, and metastasis of tumors in numerous xenograft and orthotopic in vivo models. Recently, IL-8 signaling has been implicated in regulating the transcriptional activity of the androgen receptor, underpinning the transition to an androgen-independent proliferation of prostate cancer cells. In addition, stress and drug-induced IL-8 signaling has been shown to confer chemotherapeutic resistance in cancer cells. Therefore, inhibiting the effects of IL-8 signaling may be a significant therapeutic intervention in targeting the tumor microenvironment.Keywords
This publication has 50 references indexed in Scilit:
- Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationCarcinogenesis: Integrative Cancer Research, 2008
- Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell GrowthJNCI Journal of the National Cancer Institute, 2008
- Src Continues Aging: Current and Future Clinical DirectionsClinical Cancer Research, 2007
- Transactivation of Vascular Endothelial Growth Factor Receptor-2 by Interleukin-8 (IL-8/CXCL8) Is Required for IL-8/CXCL8-induced Endothelial PermeabilityMolecular Biology of the Cell, 2007
- Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 AntagonistThe Journal of pharmacology and experimental therapeutics, 2007
- The Signaling and Biological Implications of FAK Overexpression in CancerClinical Cancer Research, 2006
- Signal processing in migrating T24 human bladder carcinoma cells: Role of the autocrine interleukin‐8 loopInternational Journal of Cancer, 2002
- Interleukin-8 Regulation of the Ras/Raf/Mitogen-activated Protein Kinase Pathway in Human NeutrophilsOnline Journal of Public Health Informatics, 1996
- Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 ReceptorScience, 1991
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991